Utilizing fluorescent life time imaging microscopy technology for identify carriers of BRCA2 mutation
- 1 November 2016
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 480 (1) , 36-41
Abstract
No abstract availableKeywords
Funding Information
- Israel Science Foundation (1702/12)
- Israel Cancer Association fund (ICA 20130179)
- Ministry of Science, Technology & Space, Israel (3-12624)
This publication has 26 references indexed in Scilit:
- Prevalence of BRCA1/2 germline mutations in 21 401 families with breast and ovarian cancerJournal of Medical Genetics, 2016
- Biophotonic endoscopy: a review of clinical research techniques for optical imaging and sensing of early gastrointestinal cancerEndoscopy International Open, 2015
- Determination of Molecular Markers for BRCA1 and BRCA2 Heterozygosity Using Gene Expression ProfilingCancer Prevention Research, 2013
- Unravelling modifiers of breast and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: update on genetic modifiersJournal of Internal Medicine, 2012
- BRCA1 and BRCA2: different roles in a common pathway of genome protectionNature Reviews Cancer, 2011
- DHPLC/SURVEYOR Nuclease: A Sensitive, Rapid and Affordable Method to Analyze BRCA1 and BRCA2 Mutations in Breast Cancer FamiliesMolecular Biotechnology, 2011
- Fluorescence Lifetime Measurements and Biological ImagingChemical Reviews, 2010
- Altered Gene Expression in Morphologically Normal Epithelial Cells from Heterozygous Carriers ofBRCA1orBRCA2MutationsCancer Prevention Research, 2010
- Cancer risks in carriers of the BRCA1/2 Ashkenazi founder mutationsJournal of Medical Genetics, 2007
- Clinical Characteristics of Individuals With Germline Mutations in BRCA1 and BRCA2: Analysis of 10,000 IndividualsJournal of Clinical Oncology, 2002